A Phase 2, Two-Group, Two-Stage, Open-Label Study of Avelumab (MSB0010718C) in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Avelumab (Primary) ; Paracetamol
- Indications Endometrial cancer
- Focus Therapeutic Use
- 06 Jun 2017 According to trial design presented at 53rd Annual Meeting of the American Society of Clinical Oncology, as of 16 patients have been enrolled, 13 on the MSS cohort and 3 on the MSI/POLE cohort.
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 27 Feb 2017 Status changed from not yet recruiting to recruiting.